FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 1.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 4.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-4 | Baclofen | 50 mg/1 g | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 028707055 | 71300-6705 | 71300-6705-4 | Baclofen | 50 mg/1 g | 2025-1 | valid | 2026-10-27 | |
| Nubratori Inc. | 71300-6705 | 71300-6705-4 | Baclofen | Baclofen | 50 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6638 | 71300-6638-4 | Baclofen | Baclofen | 50 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6635 | 71300-6635-4 | Baclofen | Baclofen | 20 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6631 | 71300-6631-1 | Dexamethasone sodium phosphate | Dexamethasone sodium phosphate | 4 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6564 | 71300-6564-1 | Dexamethasone sodium phosphate | Dexamethasone sodium phosphate | 4 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6555 | 71300-6555-1 | Dexamethasone sodium phosphate and Lidocaine HCl | DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6727 | 71300-6727-5 | Diclofenac Sodium | Diclofenac Sodium | 100 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6624 | 71300-6624-2 | Epinephrine | Epinephrine | .2 mg/.2 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6630 | 71300-6630-2 | Gabapentin | Gabapentin | 100 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6440 | 71300-6440-2 | Gabapentin | Gabapentin | 100 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6616 | 71300-6616-4 | Ketamine HCl | Ketamine HCl | 50 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6627 | 71300-6627-2 | Ketoprofen | Ketoprofen | 100 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6442 | 71300-6442-2 | Ketoprofen | Ketoprofen | 100 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6676 | 71300-6676-2 | Lidocaine | Lidocaine | 75 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6591 | 71300-6591-1 | Lidocaine HCl and Bupivacaine HCl | Lidocaine HCl and Bupivacaine HCl | 3.75 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6622 | 71300-6622-5 | LIDOCAINE HCL AND TETRACAINE HCL | Lidocaine HCl and Tetracaine HCl | 4 mg/1 mL; 2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6646 | 71300-6646-3 | Naltrexone HCl | Naltrexone HCl | 1.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6646 | 71300-6646-9 | Naltrexone HCl | Naltrexone HCl | 1.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6600 | 71300-6600-3 | Naltrexone HCl | Naltrexone HCl | 1.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6600 | 71300-6600-9 | Naltrexone HCl | Naltrexone HCl | 1.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6647 | 71300-6647-3 | NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 4.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6647 | 71300-6647-9 | NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 4.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6610 | 71300-6610-3 | NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 4.5 mg | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6610 | 71300-6610-9 | NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 4.5 mg | 2025-1 | valid | 2026-09-18 | |
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 |